These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 26973073)

  • 1. Status of vaccine research and development of vaccines for tuberculosis.
    Evans TG; Schrager L; Thole J
    Vaccine; 2016 Jun; 34(26):2911-2914. PubMed ID: 26973073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preventive vaccines for tuberculosis.
    Evans TG; Brennan MJ; Barker L; Thole J
    Vaccine; 2013 Apr; 31 Suppl 2():B223-6. PubMed ID: 23598486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Novel vaccines against M. tuberculosis].
    Okada M
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel vaccine candidates against Mycobacterium tuberculosis.
    Khoshnood S; Heidary M; Haeili M; Drancourt M; Darban-Sarokhalil D; Nasiri MJ; Lohrasbi V
    Int J Biol Macromol; 2018 Dec; 120(Pt A):180-188. PubMed ID: 30098365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New tuberculosis vaccines.
    Martín Montañés C; Gicquel B
    Enferm Infecc Microbiol Clin; 2011 Mar; 29 Suppl 1():57-62. PubMed ID: 21420568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current perspective in tuberculosis vaccine development for high TB endemic regions.
    Husain AA; Daginawala HF; Singh L; Kashyap RS
    Tuberculosis (Edinb); 2016 May; 98():149-58. PubMed ID: 27156631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is a new tuberculosis vaccine necessary and feasible? A Cuban opinion.
    Sierra VG
    Tuberculosis (Edinb); 2006; 86(3-4):169-78. PubMed ID: 16677860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tuberculosis: vaccines in the pipeline.
    Ly LH; McMurray DN
    Expert Rev Vaccines; 2008 Jul; 7(5):635-50. PubMed ID: 18564018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An update on vaccines for tuberculosis - there is more to it than just waning of BCG efficacy with time.
    Romano M; Huygen K
    Expert Opin Biol Ther; 2012 Dec; 12(12):1601-10. PubMed ID: 22957516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthetic Long Peptide Derived from Mycobacterium tuberculosis Latency Antigen Rv1733c Protects against Tuberculosis.
    Coppola M; van den Eeden SJ; Wilson L; Franken KL; Ottenhoff TH; Geluk A
    Clin Vaccine Immunol; 2015 Sep; 22(9):1060-9. PubMed ID: 26202436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The tuberculosis vaccine challenge.
    Brennan MJ
    Tuberculosis (Edinb); 2005; 85(1-2):7-12. PubMed ID: 15687021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of novel vaccines for tuberculosis control: a decision analysis study.
    Tseng CL; Oxlade O; Menzies D; Aspler A; Schwartzman K
    BMC Public Health; 2011 Jan; 11():55. PubMed ID: 21269503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current status of new tuberculosis vaccine in children.
    Pang Y; Zhao A; Cohen C; Kang W; Lu J; Wang G; Zhao Y; Zheng S
    Hum Vaccin Immunother; 2016 Apr; 12(4):960-70. PubMed ID: 27002369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Update on research and development pipeline: tuberculosis vaccines.
    Beresford B; Sadoff JC
    Clin Infect Dis; 2010 May; 50 Suppl 3():S178-83. PubMed ID: 20397946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toward novel vaccines against tuberculosis: current hopes and obstacles.
    Thaiss CA; Kaufmann SH
    Yale J Biol Med; 2010 Dec; 83(4):209-15. PubMed ID: 21165340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cattle as a model for development of vaccines against human tuberculosis.
    Buddle BM; Skinner MA; Wedlock DN; de Lisle GW; Vordermeier HM; Glyn Hewinson R
    Tuberculosis (Edinb); 2005; 85(1-2):19-24. PubMed ID: 15687023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tuberculosis vaccine development at a divide.
    Kaufmann SH
    Curr Opin Pulm Med; 2014 May; 20(3):294-300. PubMed ID: 24626237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mycobacterium tuberculosis virulence: insights and impact on vaccine development.
    Delogu G; Provvedi R; Sali M; Manganelli R
    Future Microbiol; 2015; 10(7):1177-94. PubMed ID: 26119086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antituberculous vaccine development: a perspective for the endemic world.
    Verma I; Grover A
    Expert Rev Vaccines; 2009 Nov; 8(11):1547-53. PubMed ID: 19863247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tuberculosis vaccines and prevention of infection.
    Hawn TR; Day TA; Scriba TJ; Hatherill M; Hanekom WA; Evans TG; Churchyard GJ; Kublin JG; Bekker LG; Self SG
    Microbiol Mol Biol Rev; 2014 Dec; 78(4):650-71. PubMed ID: 25428938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.